Comparison between Indo US Bio-Tech IPO and Vera Synthetic IPO.
Indo US Bio-Tech IPO is a SME Fixed Price IPO proposed to list at BSE SME while Vera Synthetic IPO is a SME Fixed Price proposed to list at NSE SME.
| Indo US Bio-Tech IPO | Vera Synthetic IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Beeline Broking Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Indo US Bio-Tech IPO is up to ₹6.92 Cr whereas the issue size of the Vera Synthetic IPO is up to ₹5.06 Cr. The final issue price of Indo US Bio-Tech IPO is ₹51.00 per share and of Vera Synthetic IPO is ₹40.00 per share.
| Indo US Bio-Tech IPO | Vera Synthetic IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹51.00 per share | ₹40.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 3000 shares |
| Fresh Issue Size | 13,56,000 shares | 12,66,000 shares |
| Fresh Issue Size (Amount) | up to ₹6.92 Cr | up to ₹5.06 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,56,000 shares | 12,66,000 shares |
| Issue Size Total (Amount) | up to ₹6.92 Cr | up to ₹5.06 Cr |
Indo US Bio-Tech IPO opens on Apr 30, 2018, while Vera Synthetic IPO opens on Mar 28, 2018. The closing date of Indo US Bio-Tech IPO and Vera Synthetic IPO is May 03, 2018, and Apr 04, 2018, respectively.
| Indo US Bio-Tech IPO | Vera Synthetic IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 30, 2018 | Mar 28, 2018 |
| Issue Close | May 03, 2018 | Apr 04, 2018 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | May 11, 2018 | Apr 12, 2018 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Indo US Bio-Tech IPO P/E ratio is , as compared to Vera Synthetic IPO P/E ratio of .
| Indo US Bio-Tech IPO | Vera Synthetic IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹24.76 Cr. | ₹19.74 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Indo US Bio-Tech IPO Retail Individual Investors (RII) are offered 6,78,000 shares while in Vera Synthetic IPO retail investors are offered 6,78,000 shares. Qualified Institutional Buyers (QIB) are offered in Indo US Bio-Tech IPO and in Vera Synthetic IPO.
| Indo US Bio-Tech IPO | Vera Synthetic IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 74,000 shares | 69,000 shares |
| QIB | ||
| NII | 6,78,000 shares | 6,33,000 shares |
| RII | 6,78,000 shares | 6,33,000 shares |
| Employee | ||
| Others | ||
| Total | 13,56,000 shares | 12,66,000 shares |
Indo US Bio-Tech IPO subscribed 19.69x in total, whereas Vera Synthetic IPO subscribed 3.49x.
| Indo US Bio-Tech IPO | Vera Synthetic IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 19.52x | 3.29x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 19.87x | 3.70x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 19.69x | 3.49x |
